## Note
nid: 1582071025000
model: AnKingOverhaul
tags: #AK_Original_Decks::Step_1::Zanki_Step_Decks::Zanki_Hematology_&_Oncology::RBC_Misc., #AK_Step1_v11::#FirstAid::10_Hematology_Oncology::05_Pharm::27_Dabrafenib_Vemurafenib, #AK_Step1_v11::#FirstAid::10_Hematology_Oncology::05_Pharm::27_Dabrafenib_Vemurafenib::Trametinib, #AK_Step1_v11::#OME_banner, #AK_Step1_v11::#Pixorize::02_Biochem::22_Onc_Drugs::17_Dabrafenib,_Vemurafenib, #AK_Step1_v11::#SketchyPharm::08_Antineoplastics::03_Kinase_Inhibitors_&_Monoclonal_Antibodies::01_Imatinib,_erlotinib,_sorafenib,_sunitinib,_vemurafenib::zanki_extra, #AK_Step1_v11::$AnKingAdds::FA2020::Hematology, #AK_Step1_v11::^Other::^HighYield::4-LowerYield, #AK_Step1_v11::^Systems::HemeOnc::RBC::AKadds
markdown: false

### Text
<b>{{c2::Trametinib}}</b> is a(n) <u>{{c1::MEK inhibitor}}</u> that
is often co-administered with <u>vemurafenib</u>

### Extra
<img src="paste-712ed328e6d6f3baa71b1b12968aea9785e1fd90.jpg">
<div><img src=
"Mechanism-of-action-of-dabrafenib-and-trametinib-binding-of-BRAF-and-MEK-inhibitors.png"></div>

### Lecture Notes


### Missed Questions


### Pathoma


### Boards and Beyond


### First Aid


### Sketchy
<a href=
"https://dashboard.sketchy.com/study/medical/courses/medical-pharmacology/units/medical-pharmacology-antineoplastics/videos/medical-pharmacology-antineoplastics-kinase-inhibitors-and-monoclonal-antibodies-imatinib-erlotinib-sorafenib-sunitinib-vemurafenib?utm_source=anki&utm_medium=partnership&utm_campaign=february_update&utm_content=medical">
Watch Imatinib, erlotinib, sorafenib, sunitinib, vemurafenib</a>

### Pixorize


### Physeo


### OME
<div class="ome-widget">
  <a href="https://onlinemeded.org?ref=anki"><img src=
  "_OME_AnkiFlashcards_General_7.png"></a>
</div>

### Additional Resources


### One by one

